Stockscreener 앱 받기
22.77
1.74%
0.39
시장 영업 전:
22.77
Baxter International Inc 주식(BAX)의 최신 뉴스
Is Baxter International Inc. stock attractive for growth fundsJuly 2025 Market Mood & Target Return Focused Picks - newser.com
How Baxter International Inc. (BAX) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Baxter names new Senior VP and Chief Accounting Officer - MSN
Will Baxter International Inc. stock beat Nasdaq index returnsEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
How Baxter International Inc. stock performs during market turbulenceMarket Weekly Review & Low Drawdown Trading Techniques - newser.com
Is Baxter International Inc. stock a buy on weaknessEarnings Performance Report & Risk Controlled Stock Pick Alerts - newser.com
Is Baxter International Inc BTL a good long term investmentEquity Performance Review & Rapid Capital Gain - earlytimes.in
Baxter International: Medical Business In Need Of A Save Itself (NYSE:BAX) - Seeking Alpha
Advanced analytics toolkit walkthrough for Baxter International Inc.Market Growth Summary & Precise Swing Trade Alerts - newser.com
How Baxter International Inc. (BTL) stock performs in volatility spikesTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
Detecting price anomalies in Baxter International Inc. with AITrade Entry Summary & High Yield Equity Trading Tips - newser.com
Baxter International Inc. (BAX) Stock Analysis: Navigating a 30% Potential Upside Amidst Industry Challenges - DirectorsTalk Interviews
Measuring Baxter International Inc.’s beta against major indicesJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Precision Trading with Baxter International Inc. (BAX) Risk Zones - news.stocktradersdaily.com
Can Baxter International Inc. (BTL) stock sustain free cash flowMarket Movers & Consistent Growth Equity Picks - newser.com
Will Baxter International Inc. stock benefit from Fed rate cutsJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Should FDA Clearance and Supply Chain Risks Drive a Reassessment of Baxter International’s (BAX) Digital Health Strategy? - simplywall.st
Baxter International (BAX): Valuation Check After U.S. National Security Probe Rattles Medical Device Sector - Yahoo Finance
I'm the former CEO of a $12 billion health care company and I serve on many boards. AI deserves a seat at the table - Fortune
U.S. Home Healthcare Market Size, Share & Trends Analysis Report 2025-2033: Focus on Neurological & Mental Disorders, Diabetes & Kidney Disorders, Cancer, Wound Care - GlobeNewswire Inc.
Baxter earns gold level resiliency badge for critical medical supplies - Investing.com India
Baxter earns gold level resiliency badge for critical medical supplies By Investing.com - Investing.com Canada
Baxter is First Manufacturer to Achieve Gold Resiliency Badge for IV Solutions, Nutrition Solutions and Premix Drugs from Healthcare Industry Resilience Collaborative (HIRC) - The Joplin Globe
Baxter International Inc. Stock Slides 3.8%, Underperforms Peers - 富途牛牛
Trump Administration Review Targets Medical Supply ChainBecton Dickinson (NYSE:BDX), Baxter Intl (NYSE:BAX) - Benzinga
Why Baxter (BAX) Stock Is Trading Lower Today - FinancialContent
Regenerative Drugs Market Review 2020-2024 and Forecast - GlobeNewswire
Baxter, GE HealthCare shares fall after US launches medical device probe By Investing.com - Investing.com South Africa
Baxter, GE HealthCare shares fall after US launches medical device probe - Investing.com Australia
Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic - Yahoo Finance
Regenerative Medicine Industry Trends and Growth - GlobeNewswire
Regenerative Medicine Industry Trends and Growth Strategies, 2025-2030 Featuring Novartis, Biogen, GlaxoSmithKline, Baxter International, and Boehringer Ingelheim - Yahoo Finance
Baxter workers rebuild lives, reestablish IV bag supply after Hurricane Helene - WCNC
Parenteral Formula Market Is Going to Boom | Major Giants Baxter International, Fresenius Kabi, B. Braun, Grifols - openPR.com
Baxter International Inc. (NYSE:BAX) Receives $30.11 Consensus Price Target from Analysts - MarketBeat
Risk vs reward if holding onto Baxter International Inc.Dividend Hike & Consistent Profit Trading Strategies - newser.com
Baxter Launches Welch Allyn Connex 360 Vital Signs Monitor to Advance Connected Patient Monitoring - biomb.ca
Baxter to split into two companies - The Covington News
Jim Cramer on Baxter: “They Are the King of Disappointment” - MSN
Fiduciary Alliance LLC Takes $1.91 Million Position in Baxter International Inc. $BAX - MarketBeat
Will BAX's Q1 Earnings Improve Following Transformation Completion? - MSN
Baxter International’s Valuation in Focus After FDA-Cleared Vital Signs Monitor Launch - simplywall.st
Rep. Lisa C. McClain Sells Off Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
AG2R LA Mondiale Gestion D Actifs Invests $1.02 Million in Baxter International Inc. $BAX - MarketBeat
Is Baxter International Stock Underperforming The Dow? - Barchart.com
1.09%
0.91%
자본화:
|
볼륨(24시간):